← Back to Analyst Consensus 
PBYI Hold
PUMA BIOTECHNOLOGY, INC.
Current Price —
Implied Upside —
Analysts 6
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 7, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Feb 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Dec 23, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Nov 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Nov 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Aug 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jul 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jun 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jun 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| May 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| May 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Mar 1, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Feb 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Sep 20, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Aug 4, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Jun 5, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| May 5, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $8 | 44% |
| Mar 6, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $8 | 44% |
| Aug 5, 2022 | HC Wainwright & Co. | maintain | — → Buy | $8 | 44% |
| May 6, 2022 | HC Wainwright & Co. | maintain | — → Buy | $12 | 44% |
| Sep 28, 2021 | Citigroup | upgrade | Neutral → Buy | $0 | 54% |
| Aug 6, 2021 | RBC Capital | maintain | — → Sector Perform | $6 | 55% |
| Aug 6, 2021 | Goldman Sachs | maintain | — → Sell | $8 | 54% |
| Aug 10, 2020 | Citigroup | maintain | — → Neutral | $12 | 54% |
| Aug 7, 2020 | SVB Leerink | maintain | — → Market Perform | $10 | — |
| May 20, 2020 | Cantor Fitzgerald | maintain | — → Neutral | $16 | 50% |
| Dec 6, 2019 | HC Wainwright & Co. | initiate | — → Buy | $15 | 44% |
| Oct 8, 2019 | Goldman Sachs | downgrade | Neutral → Sell | $8 | 54% |
| Aug 9, 2019 | Barclays | maintain | — → Underweight | $9 | 53% |
| May 10, 2019 | Citigroup | downgrade | Buy → Neutral | $24 | 54% |
| May 10, 2019 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $20 | 50% |
| Mar 1, 2019 | Citigroup | maintain | Buy → Buy | $70 | 54% |
| Jan 17, 2019 | Leerink Swann | initiate | — → Market Perform | $0 | — |
| Jan 3, 2019 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Nov 19, 2018 | Goldman Sachs | upgrade | Sell → Neutral | $28 | 54% |
| Nov 2, 2018 | JP Morgan | maintain | Underweight → Underweight | $23 | 54% |
| Nov 2, 2018 | Cantor Fitzgerald | maintain | Overweight → Overweight | $50 | 50% |
| Nov 2, 2018 | Barclays | downgrade | Equal-Weight → Underweight | $29 | 53% |
| Oct 1, 2018 | Cantor Fitzgerald | initiate | — → Overweight | $75 | 50% |
| Sep 18, 2018 | Citigroup | maintain | Buy → Buy | $151 | 54% |
| Sep 17, 2018 | Goldman Sachs | initiate | — → Sell | $42 | 54% |
| Aug 10, 2018 | JP Morgan | maintain | Overweight → Overweight | $83 | 54% |
| Jun 28, 2018 | Citigroup | maintain | Buy → Buy | $164 | 54% |
| Apr 12, 2018 | Barclays | downgrade | Overweight → Equal-Weight | $0 | 53% |
| Mar 9, 2018 | Stifel | maintain | Buy → Buy | $95 | 53% |
| Mar 2, 2018 | Barclays | maintain | Overweight → Overweight | $90 | 53% |
| Jan 24, 2018 | JP Morgan | maintain | Overweight → Overweight | $91 | 54% |
| Jan 24, 2018 | Credit Suisse | maintain | Outperform → Outperform | $106 | — |
| Jan 24, 2018 | B of A Securities | maintain | Buy → Buy | $115 | 53% |
| Jan 24, 2018 | Citigroup | maintain | Buy → Buy | $146 | 54% |
Price Target Trend
Apr 23, 2026 Latest: $6 Aug 15, 2026
EPS Estimates
0y —
+1y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days